Can-Fite BioPharma (CANF) has released an update.
Can-Fite BioPharma Ltd., a biotech firm focusing on cancer and inflammatory diseases, has announced the raising of approximately $5 million through the exercise of warrants. The company plans to use the proceeds for research and development, clinical trials, and general corporate purposes. The warrants were exercised ahead of schedule, and additional unregistered warrants were issued as part of the transaction.
For further insights into CANF stock, check out TipRanks’ Stock Analysis page.
